This publication has been discontinued on June 28, 2011.
Abstract
Executive Summary
The global Negative Pressure Wound Therapy (NPWT) market, valued at $640m in
2009, is forecast to grow by 8.2% annually for the next seven years to reach
$1.1 billion in 2016. The growth will primarily be driven by an increasing
incidence of chronic wounds, diabetes and aging population.
Globally, the US remains the largest NPWT market. The US NPWT market, valued
at $380.6m in 2009, is forecast to grow by 7.7% annually for the next seven
years to reach $594.6m in 2016. However, with most of the demand originating
from the European economies, the center of the global NPWT market activity is
due for a shift. Italy, France and Germany are forecast to grow faster than
the average global NPWT market growth. Driven by an increasing diabetic
population and increasing awareness of better diabetes and wound management,
these countries are forecast to contribute 21% in 2016.
Kinetic Concepts and Smith & Nephew remain the leading competitors in the
global NPWT market. Together, these companies accounted for 92% of the global
market share in 2008. Kinetic Concepts remained the market leader with a share
of 76%. However, small companies such as EnzySurge, with technologically
advanced products in their pipeline portfolio, are expected to attract the
most of investors' attention. The global NPWT market has witnessed intense
competition which is expected to further intensify in the years ahead.
As patients, especially in the developed economies, continue to be aware of
the latest technological developments, factors such as cost effectiveness and
effective wound management will be driving the acceptance and market
penetration of products currently in pipeline. About seven products were in
different developmental stages in 2008. DermaStream CST and V.A.C Therapy
(Japan) currently in development are the key products currently in pipeline.
DermaStream CST is in Phase II and V.A.C Therapy has received approval from in
Japan and will be commercialized in the first half of 2010. DermaStream CST
with features such as provision of continuous streaming therapy without the
need for external equipment remains the most keenly watched product in
pipeline. If approved, it will lead to an intensely competitive NPWT market
landscape.
While the prevailing market landscape remains intensely competitive, the
future could see further intensity following multiple product launches by the
leading and emerging manufacturers. More than five products, currently under
clinical investigations, are slated to receive regulatory agencies' marketing
approval by 2015. Considering the fact that the majority of these products are
technologically similar to the marketed products in terms of efficacy and
safety, the existing market leaders will not face significant challenges in
maintaining their market shares as majority of the pipeline products are being
developed by the leading competitors.
Research Methodology
GlobalData' s dedicated Research and Analysis Teams consists of experienced
professionals with a pedigree in marketing, market research and consulting in
the medical devices industry with advanced statistical expertise.
GlobalData adheres to the Codes of Practice of the Market Research Society and
the Society of Competitive Intelligence Professionals.
All GlobalData databases are continuously updated and revised.
Table of Contents
1. Table Of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2. Executive Summary
3. Global NPWT Market : Market Characterization
- 3.1 Overview
- 3.2 NPWT, Revenue ($ m), Global, 2000 - 2009
- 3.3 NPWT, Revenue ($ m), Global, 2009 - 2016
- 3.4 NPWT: Market Dynamics
- 3.4.1 Market Drivers
- 3.4.1.1 Increasing Prevalence of Chronic Wounds to Drive the NPWT
Market
- 3.4.1.2 Positive Reimbursement to Boost Adoption
- 3.4.1.3 Rise in Incidence of Diabetes Worldwide to Advance the Market
- 3.4.1.4 Aging Population and Developing Home Healthcare Sector to
Contribute to Market Development
- 3.4.2 Market Restraints
- 3.4.2.1 High Cost and Disparity in Reimbursement Levels to Hamper the
NPWT Market
- 3.4.2.2 A Large List of Contraindications for NPWT Use to Negatively
Affect Market Expansion
- 3.5 NPWT: Perception Analysis
- 3.6 NPWT: Opportunities and Unmet Need
- 3.7 Key Takeaway
4. Global NPWT Market : Competitive Assessment
- 4.1 Overview
- 4.2 Strategic Competitive Assessment
- 4.3 NPWT Company Shares 2008
- 4.3.1 Kinetic Concepts
- 4.3.2 Smith & Nephew
- 4.3.3 Others
- 4.4 Product Profiles of the Major Marketed Products in the NPWT
Market
- 4.4.1 V.A.C Therapy System
- 4.4.1.1 Overview
- 4.4.1.2 Efficacy
- 4.4.1.3 Safety Profile
- 4.4.1.4 Pricing
- 4.4.1.5 Clinical Study details
- 4.4.2 RENASYS System
- 4.4.2.1 Overview
- 4.4.2.2 Efficacy
- 4.4.2.3 Safety
- 4.4.2.4 Pricing
- 4.4.2.5 Clinical Study Details
- 4.5 Key Takeaway
5. Global NPWT Market: Pipeline Assessment
- 5.1 Overview
- 5.2 Strategic Pipeline Assessment
- 5.3 NPWT - Pipeline by Clinical Phase of Development
- 5.4 Profiles of Promising Devices in Clinical Development
- 5.4.1 DermaStream CST
- 5.4.1.1 Overview
- 5.4.1.2 Efficacy
- 5.4.1.3 Safety
- 5.4.1.4 Clinical Study Details
- 5.4.2 V.A.C. Therapy system
- 5.4.2.1 Overview
- 5.4.2.2 Efficacy
- 5.4.2.3 Safety
- 5.4.2.4 Clinical Study Details
- 5.5 NPWT Market: List of Pipeline Products
- 5.6 Key Takeaway
6. Global NPWT Market : Implications for Future Market Competition
- 6.1 Strategic Competitor Assessment
7. Global NPWT Market: Emerging Companies
- 7.1 Introduction
- 7.1.1 EnzySurge Ltd
- 7.1.1.1 Overview
- 7.1.1.2 NPWT Portfolio
8. Appendix
- 8.1 Definitions
- 8.1.1 Negative Pressure Wound Therapy (NPWT)
- 8.1.1.1 Negative Pressure Wound Therapy Disposables
- 8.1.1.2 Negative Pressure Wound Therapy Equipment
- 8.2 Research Methodology
- 8.3 Secondary Research
- 8.4 Primary Research
- 8.5 Models
- 8.6 Forecasts
- 8.7 Expert Panels
- 8.8 GlobalData Consulting
- 8.9 Contact Us
- 8.10 Disclaimer
List of Tables
- Table 1: NPWT, Revenue ($ m), Global, 2000 - 2009
- Table 2: NPWT, Revenue ($ m), Global, 2009 - 2016
- Table 3: NPWT, Company Shares, 2008
- Table 4: NPWT, Other Companies and Their Products
- Table 5: V.A.C Therapy Clinical Trial Summary - I
- Table 6: V.A.C Therapy Clinical Trial Summary - II
- Table 7: Renasys System Clinical Trial Summary
- Table 8: DermaStream CST Clinical Trial Summary
- Table 9: NPWT Pipeline Product Summary
- Table 10: EnzySurge, NPWT Pipeline Product
List of Figures
- Figure 1: NPWT, Revenue ($ m), Global, 2000 - 2009
- Figure 2: NPWT, Revenue ($ m), Global, 2009 - 2016
- Figure 3: NPWT, Opportunity and Unmet Need
- Figure 4: Strategic Competitive Assessment
- Figure 5: NPWT, Company Shares, 2008
- Figure 6: Technology Trends Analytic Framework
- Figure 7: Technology Trends Analytic Framework - Descriptions
- Figure 8: NPWT - Pipeline by Clinical Phase of Development
- Figure 9: Strategic Competitor Assessment
- Figure 10: GlobalData Methodology
